Tuesday, January 17, 2017

BRIEF-PULMATRIX DRUG CANDIDATE RECEIVES QIDP DESIGNATION FROM FDA

* PULMATRIX DRUG CANDIDATE RECEIVES "QUALIFIED INFECTIOUS

DISEASE PRODUCT" (QIDP) DESIGNATION FROM THE FDA

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)